Functional Comparison of Different Tubes for Isolating Mononuclear Cells
By LabMedica International staff writers Posted on 23 Apr 2020 |
Image: The Lymphoprep Tube is a sterile tube in that contains the Lymphoprep (separation medium) under a plastic filter disc. This is a simple and effective protocol most commonly used to isolate mononuclear cells (PBMCs) from human blood (Photo courtesy of Axis-Shield).
Profiling of immune cells with single-cell technologies is a key component of both basic science studies, evaluation of therapeutics in clinical trials, and clinical care. Cryopreserved human peripheral blood mononuclear cells (PBMCs) are a commonly used sample type for a variety of immunological assays.
Differences in PBMC sample processing techniques, including cryopreservation and thawing, can have a major influence on yield, viability, and in outcomes of downstream assays. Despite the near ubiquity of PBMC isolation, there is little standardization of processing methods across organizations and laboratories, and few studies have directly compared common differences in protocol steps.
Immunologists at Stanford University School of Medicine (Stanford, CA, USA) processed whole blood in parallel using both Cell Preparation Tubes (CPT, BD Biosciences, San Jose, CA, USA) and Lymphoprep Tubes (Axis-Shield, Dundee, UK) and assessed for yield and viability prior to cryopreservation. After thawing, samples were further examined by flow cytometry for cell yield, cell viability, frequency of 10 cell subsets, and capacity for stimulation-dependent CD4+ and CD8+ T cell intracellular cytokine production. Flow cytometry samples were acquired on a custom BD Biosciences’ 4-laser BD LSRII flow cytometer equipped with the BD FACSDiva Software.
To determine recovery rates, yield and viability of PBMCs isolated by both CPT and LP methods were verified immediately after PBMC isolation (fresh), as well as after cryopreservation for one month in liquid nitrogen. Viability was high for both methods with average values of 94.5% and 96.6% pre-freeze and 89.4% and 91.4% post-thaw for CPT and LP respectively. For each stimulation condition, there were no significant differences in the ratio of IFNγ, IL-4, and IL-17 positive T cells between the CPT or LP methods, indicating that both preserve a similar degree of T cell functionality after cryopreservation and recovery.
The potential bias of different PBMC processing methods for inadvertently depleting certain cell subsets (e.g. B cells) is a frequent point of concern when designing clinical studies. Therefore, flow cytometry was used to assess frequencies of 10 immune cell populations in PBMC samples isolated using CPT or LP methods. Frequencies of each population were not significantly different between the two isolation methods indicating no systematic loss of any cell type between CPT versus LP tubes.
The authors concluded that their results suggest that both CPT and LP Tubes are both effective methods of PBMC isolation that result in similar cell yield, viability, frequency of subsets, and capacity for stimulation-dependent T cell intracellular cytokine production. The study was published on March 30 2020 in the journal BMC Immunology.
Differences in PBMC sample processing techniques, including cryopreservation and thawing, can have a major influence on yield, viability, and in outcomes of downstream assays. Despite the near ubiquity of PBMC isolation, there is little standardization of processing methods across organizations and laboratories, and few studies have directly compared common differences in protocol steps.
Immunologists at Stanford University School of Medicine (Stanford, CA, USA) processed whole blood in parallel using both Cell Preparation Tubes (CPT, BD Biosciences, San Jose, CA, USA) and Lymphoprep Tubes (Axis-Shield, Dundee, UK) and assessed for yield and viability prior to cryopreservation. After thawing, samples were further examined by flow cytometry for cell yield, cell viability, frequency of 10 cell subsets, and capacity for stimulation-dependent CD4+ and CD8+ T cell intracellular cytokine production. Flow cytometry samples were acquired on a custom BD Biosciences’ 4-laser BD LSRII flow cytometer equipped with the BD FACSDiva Software.
To determine recovery rates, yield and viability of PBMCs isolated by both CPT and LP methods were verified immediately after PBMC isolation (fresh), as well as after cryopreservation for one month in liquid nitrogen. Viability was high for both methods with average values of 94.5% and 96.6% pre-freeze and 89.4% and 91.4% post-thaw for CPT and LP respectively. For each stimulation condition, there were no significant differences in the ratio of IFNγ, IL-4, and IL-17 positive T cells between the CPT or LP methods, indicating that both preserve a similar degree of T cell functionality after cryopreservation and recovery.
The potential bias of different PBMC processing methods for inadvertently depleting certain cell subsets (e.g. B cells) is a frequent point of concern when designing clinical studies. Therefore, flow cytometry was used to assess frequencies of 10 immune cell populations in PBMC samples isolated using CPT or LP methods. Frequencies of each population were not significantly different between the two isolation methods indicating no systematic loss of any cell type between CPT versus LP tubes.
The authors concluded that their results suggest that both CPT and LP Tubes are both effective methods of PBMC isolation that result in similar cell yield, viability, frequency of subsets, and capacity for stimulation-dependent T cell intracellular cytokine production. The study was published on March 30 2020 in the journal BMC Immunology.
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms